Michigan State University
Meet the Teams
How can we help?
Tech Transfer & Commercialization
Startups & Entrepreneurship
Browse this Section...
Search Results - james+luyendyk
Direct Thrombin Inhibitors for Diet-Induced Obesity and Fatty Liver Disease
Executive SummaryNon-alcoholic fatty liver disease (NALFD) affects approximately 20% of US adults and nearly 75% of obese adults. As NALFD becomes more severe, non-alcoholic steatohepatitis (NASH) develops, which can lead to liver failure. The only ways to treat these diseases are through weight loss, or in extreme cases, liver transplants. Researchers...
Back To Top